Monograph Details
|
|
Pain & Pyrexia
> Narcotic analgesics
|
|
PANLOR DC |
| Manufacturer |
|
PamLab, L.L.C. |
| Legal Classification |
|
CIII |
| Pharmacological Class |
|
Opioid + analgesic. |
| Generic Name |
|
Dihydrocodeine bitartrate 16mg, acetaminophen 356.4mg, caffeine 30mg; caps. |
| Also |
|
• PANLOR SS
|
| Indications |
|
Moderate to moderately severe pain. |
| Children |
|
Not recommended. |
| Adults |
|
2 caps every 4 hours as needed; max 10 caps/day. |
| Contraindications |
|
Significant respiratory depression. Acute or severe asthma. Paralytic ileus. |
| Precautions |
|
Head injury. Increased intracranial pressure. Acute abdomen. CNS depression. Coma. Shock. Volume depleted. Impaired respiratory, renal, hepatic, thyroid, or adrenocortical function. Hypotension. GI or urinary obstruction. Delirium tremens. Toxic psychosis. Seizure disorders. Drug or alcohol abusers. Avoid abrupt cessation. Elderly. Debilitated. Pregnancy (Cat.C). Nursing mothers: not recommended. |
| Interactions |
|
Potentiates alcohol, other CNS depressants. Avoid MAOIs (hypertensive crisis). Caffeine: may potentiate CNS stimulants; potentiated by disulfiram, quinolones; increase metabolism of phenobarbital, aspirin. |
| Adverse Reactions |
|
Drowsiness, dizziness, confusion, constipation, GI upset, pruritus, rash, sweating, respiratory depression, orthostatic hypotension. Overdose: hepatotoxicity. |
| How Supplied |
Tabs—100, 500
Caps—100 |
|
|
|
|
